As of 2024-07-27, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (37.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.97 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -3964.4%.
The range of the Relative Valuation is (38.28) - (37.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 28.0x - 30.1x | 29.0x |
| Fair Price | (38.28) - (37.41) | (37.50) |
| Upside | -4044.4% - -3954.8% | -3964.4% |
| Date | P/E |
| 2024-07-26 | -0.78 |
| 2024-07-25 | -0.77 |
| 2024-07-24 | -0.76 |
| 2024-07-23 | -0.74 |
| 2024-07-22 | -0.73 |
| 2024-07-19 | -0.72 |
| 2024-07-18 | -0.74 |
| 2024-07-17 | -0.79 |
| 2024-07-16 | -0.80 |
| 2024-07-15 | -0.78 |
| 2024-07-12 | -0.76 |
| 2024-07-11 | -0.77 |
| 2024-07-10 | -0.70 |
| 2024-07-09 | -0.68 |
| 2024-07-08 | -0.64 |
| 2024-07-05 | -0.66 |
| 2024-07-03 | -0.67 |
| 2024-07-02 | -0.64 |
| 2024-07-01 | -0.66 |
| 2024-06-28 | -0.70 |
| 2024-06-27 | -0.78 |
| 2024-06-26 | -0.80 |
| 2024-06-25 | -0.88 |
| 2024-06-24 | -0.89 |
| 2024-06-21 | -0.78 |
| 2024-06-20 | -0.76 |
| 2024-06-18 | -0.75 |
| 2024-06-17 | -0.78 |
| 2024-06-14 | -0.77 |
| 2024-06-13 | -0.82 |
| 2024-06-12 | -0.83 |
| 2024-06-11 | -0.81 |
| 2024-06-10 | -0.78 |
| 2024-06-07 | -0.77 |
| 2024-06-06 | -0.78 |
| 2024-06-05 | -0.80 |
| 2024-06-04 | -0.75 |
| 2024-06-03 | -0.79 |
| 2024-05-31 | -0.78 |
| 2024-05-30 | -0.76 |
| 2024-05-29 | -0.77 |
| 2024-05-28 | -0.80 |
| 2024-05-24 | -0.84 |
| 2024-05-23 | -0.88 |
| 2024-05-22 | -0.89 |
| 2024-05-21 | -0.90 |
| 2024-05-20 | -0.92 |
| 2024-05-17 | -0.93 |
| 2024-05-16 | -0.91 |
| 2024-05-15 | -0.91 |